| abstract |
(57) [Summary] [Objective] To provide a method and an ingredient for treating sepsis. The composition of the invention comprises at least free cysteine or a precursor in a physiologically and nutritionally acceptable medium, It contains cysteine in the form of a prodrug, protein or peptide hydrolyzate in a proportion of cysteine that is pharmacologically active rather than in the body of a healthy person. The percentage of cysteine is determined with respect to all amino acids present in the ingredient. |